Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
2.040
0.00 (0.00%)
At close: Apr 2, 2026, 4:00 PM EDT
2.010
-0.030 (-1.47%)
After-hours: Apr 2, 2026, 4:13 PM EDT
CDIO Market Cap
CDIO has a market cap or net worth of $6.04 million as of April 2, 2026. Its market cap has decreased by -73.51% in one year.
Market Cap
6.04M
Enterprise Value
1.62M
1-Year Change
-73.51%
Ranking
Category
Stock Price
$2.04
Market Cap Chart
Since July 26, 2022, CDIO's market cap has decreased from $368.96M to $6.04M, a decrease of -98.36%. That is a compound annual growth rate of -67.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 6.04M | 22.00% |
| Dec 31, 2025 | 4.95M | -86.66% |
| Dec 31, 2024 | 37.08M | -27.41% |
| Dec 29, 2023 | 51.09M | 406.54% |
| Dec 30, 2022 | 10.09M | -97.27% |
| Jul 26, 2022 | 368.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Processa Pharmaceuticals | 6.76M |
| Alaunos Therapeutics | 6.70M |
| Xenetic Biosciences | 6.39M |
| MetaVia | 6.38M |
| Ernexa Therapeutics | 6.31M |
| XTL Biopharmaceuticals | 6.29M |
| NuCana | 6.28M |
| Immuron | 6.27M |